These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 17325858)
1. CD5 does not regulate the signaling triggered through BCR in B cells from a subset of B-CLL patients. Perez-Chacon G; Vargas JA; Jorda J; Alvarez N; Martin-Donaire T; Rosado S; Losada-Fernandez I; Rebolleda N; Perez-Aciego P Leuk Lymphoma; 2007 Jan; 48(1):147-57. PubMed ID: 17325858 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70. Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235 [TBL] [Abstract][Full Text] [Related]
3. Negative regulation of B cell receptor-mediated signaling in B-1 cells through CD5 and Ly49 co-receptors via Lyn kinase activity. Ochi H; Watanabe T Int Immunol; 2000 Oct; 12(10):1417-23. PubMed ID: 11007759 [TBL] [Abstract][Full Text] [Related]
4. Natural phosphorylation of CD5 in chronic lymphocytic leukemia B cells and analysis of CD5-regulated genes in a B cell line suggest a role for CD5 in malignant phenotype. Gary-Gouy H; Sainz-Perez A; Marteau JB; Marfaing-Koka A; Delic J; Merle-Beral H; Galanaud P; Dalloul A J Immunol; 2007 Oct; 179(7):4335-44. PubMed ID: 17878328 [TBL] [Abstract][Full Text] [Related]
5. CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes. Garaud S; Taher TE; Debant M; Burgos M; Melayah S; Berthou C; Parikh K; Pers JO; Luque-Paz D; Chiocchia G; Peppelenbosch M; Isenberg DA; Youinou P; Mignen O; Renaudineau Y; Mageed RA Cell Mol Immunol; 2018 Feb; 15(2):158-170. PubMed ID: 27499044 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes in chronic lymphocytic leukaemia associated with expression of CD5, a negative regulator of B-cell receptor signalling. Friedman DR; Guadalupe E; Volkheimer A; Moore JO; Weinberg JB Br J Haematol; 2018 Dec; 183(5):747-754. PubMed ID: 30407619 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells. Gobessi S; Laurenti L; Longo PG; Carsetti L; Berno V; Sica S; Leone G; Efremov DG Leukemia; 2009 Apr; 23(4):686-97. PubMed ID: 19092849 [TBL] [Abstract][Full Text] [Related]
8. Survival of leukemic B cells promoted by engagement of the antigen receptor. Bernal A; Pastore RD; Asgary Z; Keller SA; Cesarman E; Liou HC; Schattner EJ Blood; 2001 Nov; 98(10):3050-7. PubMed ID: 11698290 [TBL] [Abstract][Full Text] [Related]
9. Role of CD5 in growth regulation of B-1 cells. Bondada S; Bikah G; Robertson DA; Sen G Curr Top Microbiol Immunol; 2000; 252():141-9. PubMed ID: 11125471 [TBL] [Abstract][Full Text] [Related]
10. Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells. Sen G; Bikah G; Venkataraman C; Bondada S Eur J Immunol; 1999 Oct; 29(10):3319-28. PubMed ID: 10540344 [TBL] [Abstract][Full Text] [Related]
11. Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells. Renaudineau Y; Nédellec S; Berthou C; Lydyard PM; Youinou P; Pers JO Leukemia; 2005 Feb; 19(2):223-9. PubMed ID: 15618965 [TBL] [Abstract][Full Text] [Related]
13. CD5-negative regulation of B cell receptor signaling pathways originates from tyrosine residue Y429 outside an immunoreceptor tyrosine-based inhibitory motif. Gary-Gouy H; Harriague J; Dalloul A; Donnadieu E; Bismuth G J Immunol; 2002 Jan; 168(1):232-9. PubMed ID: 11751967 [TBL] [Abstract][Full Text] [Related]
14. Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells. Tibaldi E; Brunati AM; Zonta F; Frezzato F; Gattazzo C; Zambello R; Gringeri E; Semenzato G; Pagano MA; Trentin L Leukemia; 2011 Nov; 25(11):1768-81. PubMed ID: 21701493 [TBL] [Abstract][Full Text] [Related]
15. CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC. Perez-Chacon G; Vargas JA; Jorda J; Morado M; Rosado S; Martin-Donaire T; Losada-Fernandez I; Rebolleda N; Perez-Aciego P Leuk Res; 2007 Feb; 31(2):183-93. PubMed ID: 16725198 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia. Cui B; Chen L; Zhang S; Mraz M; Fecteau JF; Yu J; Ghia EM; Zhang L; Bao L; Rassenti LZ; Messer K; Calin GA; Croce CM; Kipps TJ Blood; 2014 Jul; 124(4):546-54. PubMed ID: 24914134 [TBL] [Abstract][Full Text] [Related]
17. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia. Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435 [TBL] [Abstract][Full Text] [Related]
18. Functional studies of chronic lymphocytic leukemia B cells expressing β Uzonyi B; Mácsik-Valent B; Lukácsi S; Kiss R; Török K; Kremlitzka M; Bajtay Z; Demeter J; Bödör C; Erdei A Immunol Lett; 2017 Sep; 189():73-81. PubMed ID: 28577901 [TBL] [Abstract][Full Text] [Related]
19. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Chiorazzi N; Ferrarini M Annu Rev Immunol; 2003; 21():841-94. PubMed ID: 12615894 [TBL] [Abstract][Full Text] [Related]
20. Deregulation of Ikaros expression in B-1 cells: New insights in the malignant transformation to chronic lymphocytic leukemia. Oliveira VC; Lacerda MP; Moraes BBM; Gomes CP; Maricato JT; Souza OF; Schenkman S; Pesquero JB; Moretti NS; Rodrigues CA; Popi AF J Leukoc Biol; 2019 Sep; 106(3):581-594. PubMed ID: 31299112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]